| Nanobody; an old concept and new vehicle for immunotargeting F Rahbarizadeh, D Ahmadvand, Z Sharifzadeh Immunological investigations 40 (3), 299-338, 2011 | 140 | 2011 |
| Synthesis and antimycobacterial activity of some alkyl [5-(nitroaryl)-1, 3, 4-thiadiazol-2-ylthio] propionates A Foroumadi, Z Kargar, A Sakhteman, Z Sharifzadeh, R Feyzmohammadi, ... Bioorganic & medicinal chemistry letters 16 (5), 1164-1167, 2006 | 125 | 2006 |
| T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: towards tumor-directed oligoclonal T cell therapy FR Jamnani, F Rahbarizadeh, MA Shokrgozar, F Mahboudi, ... Biochimica et Biophysica Acta (BBA)-general subjects 1840 (1), 378-386, 2014 | 110 | 2014 |
| Genetically engineered T cells bearing chimeric nanoconstructed receptors harboring TAG-72-specific camelid single domain antibodies as targeting agents Z Sharifzadeh, F Rahbarizadeh, MA Shokrgozar, D Ahmadvand, ... Cancer letters 334 (2), 237-244, 2013 | 87 | 2013 |
| T cell engineered with a novel nanobody‐based chimeric antigen receptor against VEGFR2 as a candidate for tumor immunotherapy F Hajari Taheri, M Hassani, Z Sharifzadeh, M Behdani, A Arashkia, ... IUBMB life 71 (9), 1259-1267, 2019 | 67 | 2019 |
| Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells FR Jamnani, F Rahbarizadeh, MA Shokrgozar, D Ahmadvand, ... Experimental cell research 318 (10), 1112-1124, 2012 | 65 | 2012 |
| Construction of a chimeric antigen receptor bearing a nanobody against prostate a specific membrane antigen in prostate cancer M Hassani, F Hajari Taheri, Z Sharifzadeh, A Arashkia, J Hadjati, ... Journal of Cellular Biochemistry 120 (6), 10787-10795, 2019 | 49 | 2019 |
| Nanobodies in cell-mediated immunotherapy: On the road to fight cancer A Maali, M Gholizadeh, S Feghhi-Najafabadi, A Noei, SS Seyed-Motahari, ... Frontiers in immunology 14, 1012841, 2023 | 37 | 2023 |
| Development of oligoclonal nanobodies for targeting the tumor-associated glycoprotein 72 antigen Z Sharifzadeh, F Rahbarizadeh, MA Shokrgozar, D Ahmadvand, ... Molecular biotechnology 54 (2), 590-601, 2013 | 25 | 2013 |
| Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic viruses M Jafari, M Kadkhodazadeh, MB Shapourabadi, NH Goradel, ... Frontiers in Immunology 13, 1012806, 2022 | 22 | 2022 |
| Engineered jurkat cells for targeting prostate-specific membrane antigen on prostate cancer cells by nanobody-based chimeric antigen receptor M Hassani, FH Taheri, Z Sharifzadeh, A Arashkia, J Hadjati, ... Iranian biomedical journal 24 (2), 81, 2019 | 22 | 2019 |
| Myc decoy oligodeoxynucleotide inhibits growth and modulates differentiation of mouse embryonic stem cells as a model of cancer stem cells B Johari, M Ebrahimi-Rad, F Maghsood, M Lotfinia, Z Saltanatpouri, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017 | 22 | 2017 |
| Selection of single chain antibody fragments binding to the extracellular domain of 4-1BB receptor by phage display technology S Bagheri, M Yousefi, E Safaie Qamsari, F Riazi-Rad, M Abolhassani, ... Tumor Biology 39 (3), 1010428317695924, 2017 | 22 | 2017 |
| Synthesis, antituberculosis activity and QSAR study of some novel 2-(nitroaryl)-5-(nitrobenzylsulfinyl and sulfonyl)-1, 3, 4-thiadiazole derivatives A Foroumadi, ZZ SHARIF, HN MOHAMMAD, M VOSOUGHI, M AMINI, ... DARU JOURNAL OF PHARMACEUTICAL SCIENCE 15 (4), 218-226, 2007 | 19 | 2007 |
| Development of a human phage display-derived anti-PD-1 scFv antibody: an attractive tool for immune checkpoint therapy SS Ghaderi, F Riazi-Rad, ES Qamsari, S Bagheri, F Rahimi-Jamnani, ... BMC biotechnology 22 (1), 22, 2022 | 18 | 2022 |
| Targeting the 4-1BB costimulatory molecule through single chain antibodies promotes the human T-cell response S Bagheri, E Safaie Qamsari, M Yousefi, F Riazi-Rad, Z Sharifzadeh Cellular & Molecular Biology Letters 25, 1-13, 2020 | 18 | 2020 |
| Bactericidal fully human single‐chain fragment variable antibodies protect mice against methicillin‐resistant Staphylococcus aureus bacteraemia B Soltanmohammadi, S Piri‐Gavgani, E Basardeh, M Ghanei, M Azizi, ... Clinical & Translational Immunology 10 (7), e1302, 2021 | 13 | 2021 |
| Isolation and characterization of anti c-met single chain fragment variable (scFv) antibodies ES Qamsari, Z Sharifzadeh, S Bagheri, F Riazi-Rad, V Younesi, ... Journal of Immunotoxicology 14 (1), 23-30, 2017 | 13 | 2017 |
| Tuning spacer length improves the functionality of the nanobody-based VEGFR2 CAR T cell FH Taheri, M Hassani, Z Sharifzadeh, M Behdani, S Abdoli, M Sayadi, ... BMC biotechnology 24 (1), 1, 2024 | 6 | 2024 |
| Recent updates on allogeneic CAR-T cells in hematological malignancies S Mansoori, A Noei, A Maali, SS Seyed-Motahari, Z Sharifzadeh Cancer Cell International 24 (1), 304, 2024 | 4 | 2024 |
Mohammad Ali ShokrgozarProfessor in Medical Biotechnology, Pasteur Institute of Iran, National Cell Bank of Iran, Tehranبريد إلكتروني تم التحقق منه على pasteur.ac.ir
